Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.27
-1.35 (-4.14%)
At close: Aug 28, 2026, 4:00 PM EDT
30.76
-0.51 (-1.63%)
After-hours: Aug 28, 2026, 7:43 PM EDT

Zenas BioPharma Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Zenas BioPharma stock has a consensus rating of "Strong Buy" and an average price target of $47. The average 1-year stock price forecast is 50.30% higher than the current stock price, while the lowest is $32 (+2.33%) and the highest is $59 (+88.68%).

Price Target: $47 (+50.30%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$32$47$45$59
Change+2.33%+50.30%+43.91%+88.68%

Analyst Ratings

The average analyst rating for Zenas BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy777777
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total888888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Maintains
$22$32
HoldMaintains$22$32+2.33%Aug 17, 2026
Wedbush
Wedbush
Buy
Maintains
$45
BuyMaintains$45+43.91%Aug 14, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$55
BuyReiterates$55+75.89%Aug 14, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$44
BuyReiterates$44+40.71%Aug 14, 2026
Citi
Citi
Buy
Reiterates
$41
BuyReiterates$41+31.12%May 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
12.26M
from 10.00M
Increased by 22.60%
Revenue Next Year
53.97M
from 12.26M
Increased by 340.20%
EPS This Year
-5.62
from -4.83
EPS Next Year
-4.66
from -5.62
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-50.00M5.00M10.00M12.26M
Revenue Growth
---90.00%100.00%22.60%
Operating Income
-75.20M-27.15M-163.89M-211.39M-330.38M
Net Income
-119.28M-37.12M-156.99M-377.74M-341.03M
EPS
----4.83-5.62
Free Cash Flow
--17.64M-60.01M-143.11M-345.26M
No. Analysts
----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High57.3M
Avg12.3M
Low1,000,000

Revenue Growth

Revenue Growth202620272028
High
473.0%
Avg
22.6%
Low
-90.0%

EPS Forecast

EPS202620272028
High-5.40
Avg-5.62
Low-5.83

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-